title: Mild pre-transplant cardiomyopathy may not impair long-term quality of life after bone marrow transplantation.
abstract: An 8-year-old child with acute myeloid leukemia (AML), underwent an allogeneic bone marrow transplant (BMT) from his HLA matched sister in spite of having a mild cardiomyopathy. We followed the patient with periodic electrocardiograms (ECG) and echocardiograms which have not worsened, and the patient's quality of life is not compromised 14 years after BMT. Bone Marrow Transplantation (2000) 25, 335-336.
authors.affiliation: Department of Pediatric Hematology-Oncology, BMT Unit, University of Milan, San Gerardo Hospital, Monza, Italy.
authors.forename: B
authors.initials: B
authors.lastname: Nicolini
authors.forename: A
authors.initials: A
authors.lastname: Balduzzi
authors.forename: A
authors.initials: A
authors.lastname: Tagliabue
authors.forename: D
authors.initials: D
authors.lastname: Longoni
authors.forename: C
authors.initials: C
authors.lastname: Uderzo
authors.forename: M A
authors.initials: MA
authors.lastname: Galli
mesh_terms: D000208:Acute Disease; D018943:Anthracyclines / Q000008:administration & dosage; D016026:Bone Marrow Transplantation; D009202:Cardiomyopathies / Q000209:etiology*; D002648:Child; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004569:Electroencephalography; D006086:Graft vs Host Disease; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D017567:Karnofsky Performance Status; D007951:Leukemia, Myeloid / Q000150:complications / Q000628:therapy*; D008297:Male; D011788:Quality of Life; D014184:Transplantation, Homologous
chemical_list: D018943:Anthracyclines; D007166:Immunosuppressive Agents; D003561:Cytarabine; D003630:Daunorubicin